Display options
Share it on

BMC Chem. 2021 Jul 27;15(1):45. doi: 10.1186/s13065-021-00769-8.

Aesculin based glucosamine-6-phosphate synthase inhibitors as novel preservatives for food and pharmaceutical products: in-silico studies, antioxidant, antimicrobial and preservative efficacy evaluation.

BMC chemistry

Amit Lather, Sunil Sharma, Anurag Khatkar

Affiliations

  1. Laboratory for Preservation Technology, and Enzyme Inhibition Studies, Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.
  2. Department of Pharmaceutical Sciences, G.J.U.S.&T., Hisar, India.
  3. Laboratory for Preservation Technology, and Enzyme Inhibition Studies, Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India. [email protected].

PMID: 34315523 PMCID: PMC8317424 DOI: 10.1186/s13065-021-00769-8

Abstract

BACKGROUND: Presently available chemical based synthetic preservative have emerged with various side effects, so the aspiration of natural and side effect free novel preservative has been greatly increased. As the natural preservative exhibit poor side effect with improved preservative efficacy. The recent development in computational studies leads advancement in drug designing and discovery of novel glucosamine-6-phosphate synthase (G-6-P synthase) inhibition based natural antimicrobial preservatives. Here, selected aesculin derivatives were screened for G-6-P synthase inhibition via docking study and evaluated for antioxidant, antimicrobial, preservative efficacy as well stability study.

RESULTS: Modified aesculin derivatives were designed, synthesized and showed potent G-6-P synthase inhibition with remarkable antimicrobial, antioxidant, preservative efficacy and stability study. The molecular docking with target pdb id 1moq from G-6-P synthase resulted with better dock score and energy for compound 1 as compared to standard drugs streptomycin, ciprofloxacin, ampicillin and fluconazole, that supported the wet lab results. Among the synthesized compounds, the compound 1 possessed good antioxidant activity as compared to standard L-ascorbic acid. The resultant data for antimicrobial activity of aesculin derivatives revealed compound 1 as the most potent antimicrobial compound as compared to the standard drugs streptomycin, ciprofloxacin, ampicillin and fluconazole. While compound 2 showed better antimicrobial activity as compared to streptomycin, ciprofloxacin, ampicillin. The preservative efficacy test for compound 1 in aloe vera juice and white lotion USP has been showed the log CFU/mL values within the prescribed limit of USP standard and results were comparable to standard sodium benzoate, ethyl paraben and propyl paraben. Compound 1 has been found to be within prescribed limit of stability study over six month.

CONCLUSION: Compound 1 showed the potent G-6-P synthase inhibitory, antioxidant, antimicrobial, preservative efficacy and stability study results as compared to standard drugs taken. The results have found comparable to molecular docking results, and this final compound may be used as new preservatives for food and pharmaceutical products. Moreover, the mechanistic insight into the docking poses was also explored by binding interactions of aesculin derivatives inside the pdb id 1moq. These results also supported the results for novel synthesized G-6-P synthase inhibitors.

© 2021. The Author(s).

Keywords: Aesculin; Docking; G-6-P synthase; Parabens; Preservative

References

  1. J Appl Toxicol. 2008 Jul;28(5):561-78 - PubMed
  2. Free Radic Res. 2004 Aug;38(8):839-46 - PubMed
  3. J Med Chem. 2002 Jun 6;45(12):2615-23 - PubMed
  4. Structure. 1998 Aug 15;6(8):1047-55 - PubMed
  5. J Food Sci Technol. 2011 Oct;48(5):525-33 - PubMed
  6. J Biol Chem. 2000 Jan 7;275(1):135-40 - PubMed
  7. Reprod Toxicol. 2009 Jan;27(1):1-7 - PubMed
  8. Nat Rev Drug Discov. 2002 Sep;1(9):727-30 - PubMed
  9. Nat Rev Drug Discov. 2004 Nov;3(11):935-49 - PubMed
  10. Nat Rev Drug Discov. 2005 Mar;4(3):206-20 - PubMed
  11. Comb Chem High Throughput Screen. 2017;20(6):474-491 - PubMed
  12. Acta Biochim Pol. 2005;52(3):647-53 - PubMed
  13. Phys Chem Chem Phys. 2013 May 28;15(20):7731-9 - PubMed
  14. J Med Chem. 2004 Mar 25;47(7):1739-49 - PubMed
  15. Comb Chem High Throughput Screen. 2018;21(3):182-193 - PubMed
  16. J Antimicrob Chemother. 2001 Jul;48 Suppl 1:5-16 - PubMed
  17. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2017 Sep 19;52(11):1041-1045 - PubMed
  18. Fundam Clin Pharmacol. 2017 Apr;31(2):174-184 - PubMed

Publication Types